Kestra Medical Technologies, Ltd.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.68 USD
−113.81 M USD
59.81 M USD
19.43 M
About Kestra Medical Technologies, Ltd.
Sector
Industry
CEO
Brian Webster
Website
Headquarters
Kirkland
Founded
2014
IPO date
Mar 6, 2025
IPO offer price
17.00 USD
Identifiers
3
ISIN BMG524411052
Kestra Medical Technologies Ltd. is a commercial-stage, wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company was founded by Brian Webster and Phillip D. Foshee in 2014 and is headquartered in Kirkland, WA.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of KMTS is 26.21 USD — it has increased by 1.01% in the past 24 hours. Watch Kestra Medical Technologies, Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Kestra Medical Technologies, Ltd. stocks are traded under the ticker KMTS.
KMTS stock has fallen by −0.52% compared to the previous week, the month change is a 9.89% rise, over the last year Kestra Medical Technologies, Ltd. has showed a 14.18% increase.
We've gathered analysts' opinions on Kestra Medical Technologies, Ltd. future price: according to them, KMTS price has a max estimate of 32.00 USD and a min estimate of 25.00 USD. Watch KMTS chart and read a more detailed Kestra Medical Technologies, Ltd. stock forecast: see what analysts think of Kestra Medical Technologies, Ltd. and suggest that you do with its stocks.
KMTS reached its all-time high on Oct 27, 2025 with the price of 30.00 USD, and its all-time low was 13.25 USD and was reached on Jul 16, 2025. View more price dynamics on KMTS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
KMTS stock is 4.62% volatile and has beta coefficient of 1.17. Track Kestra Medical Technologies, Ltd. stock price on the chart and check out the list of the most volatile stocks — is Kestra Medical Technologies, Ltd. there?
Today Kestra Medical Technologies, Ltd. has the market capitalization of 1.55 B, it has increased by 3.74% over the last week.
Yes, you can track Kestra Medical Technologies, Ltd. financials in yearly and quarterly reports right on TradingView.
Kestra Medical Technologies, Ltd. is going to release the next earnings report on Apr 20, 2026. Keep track of upcoming events with our Earnings Calendar.
KMTS earnings for the last quarter are −0.64 USD per share, whereas the estimation was −0.59 USD resulting in a −7.72% surprise. The estimated earnings for the next quarter are −0.60 USD per share. See more details about Kestra Medical Technologies, Ltd. earnings.
Kestra Medical Technologies, Ltd. revenue for the last quarter amounts to 22.57 M USD, despite the estimated figure of 20.72 M USD. In the next quarter, revenue is expected to reach 23.01 M USD.
KMTS net income for the last quarter is −32.78 M USD, while the quarter before that showed −25.83 M USD of net income which accounts for −26.95% change. Track more Kestra Medical Technologies, Ltd. financial stats to get the full picture.
No, KMTS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 8, 2026, the company has 330 employees. See our rating of the largest employees — is Kestra Medical Technologies, Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Kestra Medical Technologies, Ltd. EBITDA is −121.32 M USD, and current EBITDA margin is −164.52%. See more stats in Kestra Medical Technologies, Ltd. financial statements.
Like other stocks, KMTS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Kestra Medical Technologies, Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Kestra Medical Technologies, Ltd. technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Kestra Medical Technologies, Ltd. stock shows the buy signal. See more of Kestra Medical Technologies, Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.